Familial Hypercholesterolemia: Screening, diagnosis and management of pediatric and adult patients

Goldberg, Anne C., Hopkins, Paul N., Toth, Peter P., Ballantyne, Christie M., Rader, Daniel J., Robinson, Jennifer G., Daniels, Stephen R., Gidding, Samuel S., de Ferranti, Sarah D., Ito, Matthew K., McGowan, Mary P., Moriarty, Patrick M., Cromwell, William C., Ross, Joyce L., Ziajka, Paul E.·2011·Journal of clinical lipidology
DOI 10.1016/j.jacl.2011.03.001

Cited by (622)

Items 101–200 of 622

  1. Leveraging Implementation Science to Address Health Disparities in Genomic Medicine: Examples from the Field
    Megan Clarke Roberts, George A. Mensah, Muin J. Khoury · 2019 · Ethnicity & Disease
  2. Prevalence of familial hypercholesterolemia in patients with acute coronary syndrome in Japan: Results of the EXPLORE-J study
    Mariko Harada‐Shiba, Junya Ako, Hidenori Arai, Atsushi Hirayama, Yoshitaka Murakami, Atsushi Nohara, Asuka Ozaki, Kiyoko Uno, Masato Nakamura · 2018 · Atherosclerosis
  3. Identification of people with heterozygous familial hypercholesterolemia
    Haase, Annie, Goldberg, Anne C. · 2012 · Current Opinion in Lipidology
  4. Statins and other lipid-lowering therapy and pregnancy outcomes in homozygous familial hypercholesterolaemia: A retrospective review of 39 pregnancies
    Botha, Theunis C., Pilcher, Gillian J., Wolmarans, Karen, Blom, Dirk J., Raal, Frederick J. · 2018 · Atherosclerosis
  5. Prevention of cardiovascular disease in patients with familial hypercholesterolaemia: The role of PCSK9 inhibitors
    Ivan Pećin, Merel L. Hartgers, G. Kees Hovingh, Ricardo E. Dent, Željko Reiner · 2017 · European Journal of Preventive Cardiology
  6. Reducing the burden of disease and death from familial hypercholesterolemia: A call to action
    Joshua W. Knowles, Emily Claire O'Brien, Karen Greendale, Katherine A. Wilemon, Jacques J. Genest, Laurence S. Sperling, William A. Neal, Daniel James Rader, Muin J. Khoury · 2014 · American Heart Journal
  7. Diet and Cardiovascular Disease Risk Among Individuals with Familial Hypercholesterolemia: Systematic Review and Meta-Analysis
    Fotios Barkas, Tzortzis Nomikos, Evangelos N. Liberopoulos, Demosthenes B. Panagiotakos · 2020 · Nutrients
  8. LP(a): Structure, Genetics, Associated Cardiovascular Risk, and Emerging Therapeutics
    Erfan Tasdighi, Rishav Adhikari, Omar Almaadawy, Thorsten Martin Leucker, Michael Joseph Blaha · 2023 · The Annual Review of Pharmacology and Toxicology
  9. Women Living with Familial Hypercholesterolemia: Challenges and Considerations Surrounding Their Care
    Sujana Balla, Eson Ekpo, Katherine A. Wilemon, Joshua W. Knowles, Fátima Rodríguez · 2020 · Current Atherosclerosis Reports
  10. Precision Cardiovascular Medicine: State of Genetic Testing
    John R. Giudicessi, Iftikhar J. Kullo, Michael John Ackerman · 2017 · Mayo Clinic Proceedings
  11. Long-Term Statin Treatment in Children with Familial Hypercholesterolemia: More Insight into Tolerability and Adherence
    Marjet J.A.M. Braamskamp, D. Meeike Kusters, Hans J. Avis, Ellen M. A. Smets, Frits A. Wijburg, John J.P. Kastelein, Albert Wiegman, Barbara A. Hutten · 2015 · Pediatric Drugs
  12. Spontaneous severe hypercholesterolemia and atherosclerosis lesions in rabbits with deficiency of low-density lipoprotein receptor (LDLR) on exon 7
    Rui Lü, Tingting Yuan, Yingge Wang, Ting Zhang, Yuguo Yuan, Daijin Wu, Minya Zhou, Zhengyi He, Yaoyao Lu, Yajie Chen et al. · 2018 · EBioMedicine
  13. Criteria for Diagnosis of Familial Hypercholesterolemia: A Comprehensive Analysis of the Different Guidelines, Appraising their Suitability in the Omani Arab Population
    Khalid Al‐Rasadi, Khalid Al-Waili, Hilal Ali Al-Sabti, Ali Talib Al-Hinai, Khamis Al-Hashmi, Ibrahim S Al-Zakwani, Yajnavalka Banerjee · 2014 · Oman Medical Journal
  14. Proprotein Convertase Subtilisin/Kexin 9 Inhibitors
    Simona Ruxanda Dragan, Maria-Corina Șerban, Maciej Banach · 2014 · Journal of Cardiovascular Pharmacology and Therapeutics
  15. New Genetic Insights into Congenital Heart Disease
    Stephanie M. Ware, John L. Jefferies · 2012 · Journal of Clinical & Experimental Cardiology
  16. Familial Hypercholesterolemia: New Horizons for Diagnosis and Effective Management
    Maria G. Mytilinaiou, Ioannis Kyrou, Mike Khan, Dimitris K Grammatopoulos, Harpal Singh Randeva · 2018 · Frontiers in Pharmacology
  17. 2013 ACC/AHA Cholesterol Treatment Guideline
    Seth Shay Martin, Thura T. Abd, Steven Richard Jones, Erin D. Michos, Roger Scott Blumenthal, Michael Joseph Blaha · 2014 · Journal of the American College of Cardiology
  18. Enhancing the value of PCSK9 monoclonal antibodies by identifying patients most likely to benefit. A consensus statement from the National Lipid Association
    Jennifer G. Robinson, Manju Bengaluru Jayanna, Alan S. Brown, Karen E. Aspry, Carl E. Orringer, Edward Allen Gill, Anne Carol Goldberg, Laney K. Jones, Kevin Carl Maki, Dave L. Dixon et al. · 2019 · Journal of clinical lipidology
  19. Challenges in the Diagnosis and Treatment of Homozygous Familial Hypercholesterolemia
    Matthew K. Ito, Gerald Francis Watts · 2015 · Drugs
  20. Risk stratification of patients with familial hypercholesterolemia in a multi-ethnic cohort
    Matthew D Allard, Ramesh Saeedi, Masoud Yousefi, Jiri J Frohlich · 2014 · Lipids in Health and Disease
  21. Cystic fibrosis foundation position paper: Redefining the CF care model
    Danielle Goetz, Rebekah F. Brown, Stephanie Spear Filigno, Stacy Bichl, Alison L. Nelson, C.A. Merlo, Richard Juel, P. Lomas, Sarah E. Hempstead, Q. Tran et al. · 2024 · Journal of Cystic Fibrosis
  22. Optimising the Detection and Management of Familial Hypercholesterolaemia: Central Role of Primary Care and its Integration with Specialist Services
    Alistair W. Vickery, Damon A. Bell, Jacquie Garton‐Smith, Andrew B. Kirke, Jing Pang, Gerald Francis Watts · 2014 · Heart Lung and Circulation
  23. Diagnóstico y tratamiento de la hipercolesterolemia familiar en España: documento de consenso
    Pedro Mata, Rodrigo Alonso K, Antonio Ruiz, José Ramón González‐Juanatey, Lina Badimón, José Luis Díaz-Díaz, María Teresa Múñoz, Ovidio Muñiz-Grijalvo, Enrique Galve, Luis Irigoyen et al. · 2014 · Atención Primaria
  24. The UK Paediatric Familial Hypercholesterolaemia Register: preliminary data
    Uma Ramaswami, Jackie A. Cooper, Steve Eric Humphries · 2016 · Archives of Disease in Childhood
  25. Familial Hypercholesterolemia: A Systematic Review of Guidelines on Genetic Testing and Patient Management
    Giuseppe Migliara, Valentina Baccolini, Annalisa Rosso, Elvira D’Andrea, Azzurra Massimi, Paolo Villari, Corrado De Vito · 2017 · Frontiers in Public Health
  26. Barriers to Early Diagnosis and Treatment of Familial Hypercholesterolemia: Current Perspectives on Improving Patient Care
    Rodrigo Alonso K, Leopoldo Pérez de Isla, Ovidio Muñiz-Grijalvo, Pedro Mata · 2020 · Vascular Health and Risk Management
  27. Combination therapy in dyslipidemia: Where are we now?
    Alberico Luigi Catapano, Michel Farnier, JoAnne Micale Foody, Peter Paul Toth, Joanne E. Tomassini, Philippe Brudi, Andrew M. Tershakovec · 2014 · Atherosclerosis
  28. Update on the laboratory investigation of dyslipidemias
    Ramasamy, I. · 2018 · Clinica Chimica Acta
  29. MicroRNAs Involved in the Lipid Metabolism and Their Possible Implications for Atherosclerosis Development and Treatment
    Jan Novák, Julie Bienertová Vašků, Tomáš Kára, Miroslav Novák · 2014 · Mediators of Inflammation
  30. Current view: indications for extracorporeal lipid apheresis treatment
    The German Apheresis Working Group, Volker J. J. Schettler, C. L. Neumann, Martin Hulpke‐Wette, Gerrit C. Hagenah, Egbert Godehard Schulz, Eberhard Wieland · 2012 · Clinical Research in Cardiology Supplements
  31. Significant gaps in awareness of familial hypercholesterolemia among physicians in selected Asia-Pacific countries: A pilot study
    Jing Pang, DAVID R. SULLIVAN, Mariko Harada‐Shiba, Phillip Y.A. Ding, Sheryl Selvey, Shariq Ali, Gerald Francis Watts · 2014 · Journal of clinical lipidology
  32. Screening for familial hypercholesterolaemia in primary care: Time for general practice to play its part
    Tom Brett, Nadeem Qureshi, Samuel S. Gidding, Gerald Francis Watts · 2018 · Atherosclerosis
  33. The UK Paediatric Familial Hypercholesterolaemia Register: Statin-related safety and 1-year growth data
    Steve Eric Humphries, Jackie A. Cooper, Peter Dale, Uma Ramaswami · 2017 · Journal of clinical lipidology
  34. Prevalence of familial hypercholesterolemia: a meta-analysis of six large, observational, population-based studies in Poland
    Andrzej Pająk, Krystyna Szafraniec, Maciej Polak, Wojciech Drygas, Walerian Piotrowski, Tomasz Roman Zdrojewski, Piotr Jankowski · 2016 · Archives of Medical Science
  35. Knowns and unknowns in the care of pediatric familial hypercholesterolemia
    Andrew C. Martin, Samuel S. Gidding, Albert Wiegman, Gerald Francis Watts · 2017 · Journal of Lipid Research
  36. Existing and emerging therapies for the treatment of familial hypercholesterolemia
    Robert S. Rosenson · 2021 · Journal of Lipid Research
  37. Improved cardiovascular outcomes following temporal advances in lipid-lowering therapy in a genetically-characterised cohort of familial hypercholesterolaemia homozygotes
    Gilbert R. Thompson, Mary Seed, Rossi P. Naoumova, Clare K. Y. Neuwirth, Shahenaz Walji, Timothy J. Aitman, James Scott, Nicolas B. Myant, Anne K. Soutar · 2015 · Atherosclerosis
  38. The genetics of familial hypercholesterolemia and emerging therapies
    Anja Vogt · 2015 · The Application of Clinical Genetics
  39. Effectiveness of alternative strategies to define index case phenotypes to aid genetic diagnosis of familial hypercholesterolaemia
    Rosemary E. Clarke, Soundrie T. Padayachee, Rebecca Preston, Zofia McMahon, Mitchell Gordon, Colin Alexander Graham, Martin Andrew Crook, Anthony S. Wierzbicki · 2012 · Heart
  40. LOWER, a registry of lomitapide-treated patients with homozygous familial hypercholesterolemia: Rationale and design
    Dirk Jacobus Blom, Zahi Adel Fayad, John J.P. Kastelein, Dominique G. Larrey, Lukas Makris, Charles Schwamlein, LeAnne Bloeden, James A. Underberg · 2015 · Journal of clinical lipidology
  41. Pediatric experience with mipomersen as adjunctive therapy for homozygous familial hypercholesterolemia
    Frederick Johan Raal, Marjet J.A.M. Braamskamp, Sheryl Selvey, Charlotte Sensinger, John J.P. Kastelein · 2016 · Journal of clinical lipidology
  42. The lipid-lowering effects of lomitapide are unaffected by adjunctive apheresis in patients with homozygous familial hypercholesterolaemia – A post-hoc analysis of a Phase 3, single-arm, open-label trial
    Claudia Stefanutti, Dirk Jacobus Blom, Maurizio Rocco Averna, Emma Anne Meagher, Hendrik du Toit Theron, Adrian David Marais, Robert Alexander Hegele, Cesare Riccardo Sirtori, Prediman K. Shah, Daniel Gaudet et al. · 2015 · Atherosclerosis
  43. High burden of recurrent cardiovascular events in heterozygous familial hypercholesterolemia: The French Familial Hypercholesterolemia Registry
    Sophie Béliard, Franck Boccara, Bertrand Cariou, Alain Carrié, Xavier Collet, Michel Farnier, Jean Ferrières, Michael Krempf, Noël Peretti, Jean‐Pierre Rabès et al. · 2018 · Atherosclerosis
  44. Evidence-Based Policy Making: Assessment of the American Heart Association’s Strategic Policy Portfolio
    Darwin R. Labarthe, Larry B. Goldstein, Elliott Marshall Antman, Donna K. Arnett, Gregg C. Fonarow, Mark J. Alberts, Laura Lucia Hayman, Amit Khera, James F. Sallis, Stephen R. Daniels et al. · 2016 · Circulation
  45. Management of lipid disorders in patients living with HIV
    Merle L. Myerson, Carlos Malvestutto, Judith A. Aberg · 2015 · The Journal of Clinical Pharmacology
  46. Lipid treatment and goal attainment characteristics among persons with atherosclerotic cardiovascular disease in the United States
    Klimchak, Alexa C., Patel, Miraj Y., Iorga, Şerban R., Kulkarni, Natasha, Wong, Nathan D. · 2020 · American Journal of Preventive Cardiology
  47. Early diagnosis and treatment of familial hypercholesterolemia: improving patient outcomes
    Rodrigo Alonso K, Pedro Mata, Daniel Zambón, Nelva Mata, Francisco J. Fuentes · 2013 · Expert Review of Cardiovascular Therapy
  48. Statins decrease the risk of stroke in individuals with heterozygous familial hypercholesterolemia: A systematic review and meta-analysis
    Fotios Barkas, Moses Elisaf, Haralampos J. Milionis · 2015 · Atherosclerosis
  49. My Approach to the Patient With Familial Hypercholesterolemia
    Maya S. Safarova, Iftikhar J. Kullo · 2016 · Mayo Clinic Proceedings
  50. Aerobic exercise reduces triglycerides by targeting apolipoprotein C3 in patients with coronary heart disease
    Yating Wang, Li Shen, Danyan Xu · 2018 · Clinical Cardiology
  51. HDL-small RNA Export, Transport, and Functional Delivery in Atherosclerosis
    Kasey C. Vickers, Danielle L. Michell · 2021 · Current Atherosclerosis Reports
  52. Translational Research for Improving the Care of Familial Hypercholesterolemia: The “Ten Countries Study” and Beyond
    Gerald Francis Watts, Phillip Y.A. Ding, Peter Myles George, Martin S. Hagger, Miao Hu, Jie Lin, Khoo Kah Lin, Adrian David Marais, Takashi Miida, Hapizah Mohd Nawawi et al. · 2016 · Journal of Atherosclerosis and Thrombosis
  53. Current Approach to the Diagnosis and Treatment of Heterozygote and Homozygous FH Children and Adolescents
    Hofit Cohen, Claudia Stefanutti, Serafina Di Giacomo, Claudia Morozzi, Kurt Widhalm, Bojko B. Bjelakovic, Andrea Berni, Francesco Martino, Giovanna Bosco · 2021 · Current Atherosclerosis Reports
  54. Familial hypercholesterolemia and estimation of US patients eligible for low-density lipoprotein apheresis after maximally tolerated lipid-lowering therapy
    Raghu L. Vishwanath, Linda Hemphill · 2013 · Journal of clinical lipidology
  55. Laboratory assessment of cardiometabolic risk in overweight and obese children
    Grażyna Sypniewska · 2015 · Clinical Biochemistry
  56. Familial hypercholesterolemia/autosomal dominant hypercholesterolemia: Molecular defects, the LDL-C continuum, and gradients of phenotypic severity
    JoAnne Micale Foody, Raghu L. Vishwanath · 2016 · Journal of clinical lipidology
  57. A 3-year study of atorvastatin in children and adolescents with heterozygous familial hypercholesterolemia
    Gisle Langslet, Andrei Breazna, Euridiki Drogari · 2016 · Journal of clinical lipidology
  58. Improving Universal Pediatric Lipid Screening
    Kathleen DeSantes, Ann Dodge, Jens C. Eickhoff, Amy Lynn Hering Peterson · 2017 · The Journal of Pediatrics
  59. A mussel-inspired approach towards heparin-immobilized cellulose gel beads for selective removal of low density lipoprotein from whole blood
    Yupei Li, Mei Han, Yilin Wang, Qiang Liu, Weifeng Zhao, Baihai Su, Changsheng Zhao · 2018 · Carbohydrate Polymers
  60. Comparative aspects of the care of familial hypercholesterolemia in the “Ten Countries Study”
    Jing Pang, Dick C. Chan, Miao Hu, Lauretta A. Muir, See Kwok, Min‐Ji Charng, Christopher Michael Florkowski, Peter Myles George, Jie Lin, Đỗ Doãn Lợi et al. · 2019 · Journal of clinical lipidology
  61. Barriers and Facilitators to Genetic Testing for Familial Hypercholesterolemia in the United States: A Review
    Rachele Hendricks‐Sturrup, Kathleen M. Mazor, Amy Curry Sturm, Christine Y. Lu · 2019 · Journal of Personalized Medicine
  62. Diet-induced dyslipidemia induces metabolic and migratory adaptations in regulatory T cells
    Jacob Amersfoort, Frank H. Schaftenaar, Hidde Douna, Peter J. van Santbrink, Gijs H.M. van Puijvelde, Bram Slütter, Amanda C. Foks, Amy C. Harms, Estefanía Moreno-Gordaliza, Yanyan Wang et al. · 2020 · Cardiovascular Research
  63. Early Prevention of Atherosclerosis: Detection and Management of Hypercholesterolaemia in Children and Adolescents
    Cristina Pederiva, Maria Elena Capra, Claudia Viggiano, Valentina Rovelli, Giuseppe Banderali, Giacomo Biasucci · 2021 · Life
  64. Statins do not increase the risk of developing type 2 diabetes in familial hypercholesterolemia: The SAFEHEART study
    Francisco J. Fuentes, Juan Francisco Alcala-Diaz, Gerald Francis Watts, Rodrigo Alonso K, Ovidio Muñiz-Grijalvo, José Luis Díaz-Díaz, Nelva Mata, Juan Francisco Sánchez Muñoz-Torrero, Ángel Brea, Jesús Galiana et al. · 2015 · International Journal of Cardiology
  65. Health Screening Behaviour among Singaporeans
    Hui Zhen Wong, Wei‐Yen Lim, Stefan SL, Lily Ai Vee Chua, Derrick Heng · 2015 · Annals of the Academy of Medicine Singapore
  66. How Can We Reach At-Risk Relatives? Efforts to Enhance Communication and Cascade Testing Uptake: a Mini-Review
    Rachel Schwiter, Alanna Kulchak Rahm, Janet L. Williams, Amy Curry Sturm · 2018 · Current Genetic Medicine Reports
  67. Successful Genetic Screening and Creating Awareness of Familial Hypercholesterolemia and Other Heritable Dyslipidemias in the Netherlands
    Linda C. Zuurbier, Joep C. Defesche, Albert Wiegman · 2021 · Genes
  68. Prevalence of potential familial hypercholesterolemia (FH) in 54,811 statin-treated patients in clinical practice
    Alberico Luigi Catapano, Dominik Lautsch, Lale S Tokgözoğlu, Jean Ferrières, Martin Horack, Michel Farnier, Peter Paul Toth, Philippe Brudi, Joanne E. Tomassini, Baishali M. Ambegaonkar et al. · 2016 · Atherosclerosis
  69. In pediatric familial hypercholesterolemia, lipoprotein(a) is more predictive than LDL-C for early onset of cardiovascular disease in family members
    Amy W. Zawacki, Ann Dodge, Kaitlin M. Woo, J. Carter Ralphe, Amy Lynn Hering Peterson · 2018 · Journal of clinical lipidology
  70. Barriers to the identification of familial hypercholesterolemia among primary care providers
    John Zimmerman, Daniel A. Duprez, Patricia McCarthy Veach, Heather A. Zierhut · 2018 · Journal of Community Genetics
  71. Comparison of the mutation spectrum and association with pre and post treatment lipid measures of children with heterozygous familial hypercholesterolaemia (FH) from eight European countries
    Marta Futema, Uma Ramaswami, Lukáš Tichý, Martin Prøven Bogsrud, Kirsten Bjørklund Holven, Jeanine E. Roeters van Lennep, Albert Wiegman, Olivier S Descamps, Anne De Leener, Elodie Fastré et al. · 2021 · Atherosclerosis
  72. Management of familial hypercholesterolemia in children and adolescents. Position paper of the Polish Lipid Expert Forum
    Małgorzata Myśliwiec, Mieczysław Walczak, Ewa Małecka‐Tendera, Anna Dobrzańska, Barbara Cybulska, Krzysztof Jerzy Filipiak, Artur Mazur, Przemysława A. Jarosz-Chobot, Agnieszka Szadkowska, Andrzej Rynkiewicz et al. · 2014 · Journal of clinical lipidology
  73. Mipomersen preferentially reduces small low-density lipoprotein particle number in patients with hypercholesterolemia
    Raul Dias Santos, Frederick Johan Raal, Joanne M. Donovan, William C. Cromwell · 2014 · Journal of clinical lipidology
  74. Lomitapide: A Review of its Use in Adults with Homozygous Familial Hypercholesterolemia
    Caroline M. Perry · 2013 · American Journal of Cardiovascular Drugs
  75. Dietary counseling is associated with an improved lipid profile in children with familial hypercholesterolemia
    Kristin Torvik, Ingunn Narverud, Inger Olaug Ottestad, Arne Svilaas, Jon Michael Gran, Kjetil Retterstøl, Asta Ellingvåg, Ellen Strøm, Leiv Ose, Marit Bragelien Veierød et al. · 2016 · Atherosclerosis
  76. Characteristics and management of 1093 patients with clinical diagnosis of familial hypercholesterolemia in Greece: Data from the Hellenic Familial Hypercholesterolemia Registry (HELLAS-FH)
    Christos V. Rizos, Moses Elisaf, Ioannis Skoumas, Κωνσταντίνος Τζιόμαλος, Vasilios Kotsis, Lοukianos S. Rallidis, Anastasia Garoufi, Vasilios Gabriel Athyros, Emmanouil I. Skalidis, Genovefa D. Kolovou et al. · 2018 · Atherosclerosis
  77. Apheresis for severe hypercholesterolaemia and elevated lipoprotein(a)
    Elisa Waldmann, Klaus Georg Parhofer · 2019 · Pathology
  78. Dyslipidemia: Management Using Optimal Lipid-Lowering Therapy
    Matthew K. Ito · 2012 · Annals of Pharmacotherapy
  79. Pregnancy in homozygous familial hypercholesterolemia – Importance of LDL-apheresis
    Milan Blaha, Miriam Lánská, Vladimir Blaha, L Boudys, Павел Зак · 2015 · Atherosclerosis Supplements
  80. Progress in the care of common inherited atherogenic disorders of apolipoprotein B metabolism
    Katrina L. Ellis, Amanda J. Hooper, John R. Burnett, Gerald Francis Watts · 2016 · Nature Reviews Endocrinology
  81. Investigation of possible effects of microRNAs involved in regulation of lipid metabolism in the pathogenesis of atherosclerosis
    Ayşegül Görür, Ahmet Çelik, Didem Derici Yıldırım, Ahmet Gündeş, Lülüfer Tamer · 2019 · Molecular Biology Reports
  82. Knowing the Prevalence of Familial Hypercholesterolemia Matters
    Anne Carol Goldberg, Samuel S. Gidding · 2016 · Circulation
  83. International Developments in the Care of Familial Hypercholesterolemia: Where Now and Where to Next?
    Jing Pang, Peter J. Lansberg, Gerald Francis Watts · 2016 · Journal of Atherosclerosis and Thrombosis
  84. Targeting microsomal triglyceride transfer protein and lipoprotein assembly to treat homozygous familial hypercholesterolemia
    Meghan T. Walsh, M. Mahmood Hussain · 2016 · Critical Reviews in Clinical Laboratory Sciences
  85. Lipid-modifying therapy and low-density lipoprotein cholesterol goal attainment in patients with familial hypercholesterolemia in Germany: The CaReHigh Registry
    Nina Schmidt, Alexander Dressel, Tanja B. Grammer, Ioanna Gouni‐Berthold, Ulrich Julius, Ursula Kassner, Gerald Klose, Christel König, Wolfgang Köenig, Britta Otte et al. · 2018 · Atherosclerosis
  86. Antisense therapy and emerging applications for the management of dyslipidemia
    Peter Paul Toth · 2011 · Journal of clinical lipidology
  87. The role of antisense oligonucleotide therapy in patients with familial hypercholesterolemia: risks, benefits, and management recommendations
    Agarwala, Anandita, Jones, Peter, Nambi, Vijay · 2015 · Current Atherosclerosis Reports
  88. Genetic testing in ambulatory cardiology clinics reveals high rate of findings with clinical management implications
    David R. Murdock, Eric Venner, Donna Marie Muzny, Ginger Metcalf, Mullai Murugan, Trevor D. Hadley, Varuna Chander, Paul S. de Vries, Xiaoming Jia, Aliza Hussain et al. · 2021 · Genetics in Medicine
  89. Management of familial heterozygous hypercholesterolemia: Position Paper of the Polish Lipid Expert Forum
    Andrzej Rynkiewicz, Barbara Cybulska, Maciej Banach, Krzysztof Jerzy Filipiak, Tomasz Jan Guzik, Barbara Idzior−Waluś, Jacek Imiela, Piotr Jankowski, Longina Kłosiewicz−Latoszek, Janusz Limon et al. · 2013 · Journal of clinical lipidology
  90. Early Left Ventricular Abnormalities in Children with Heterozygous Familial Hypercholesterolemia
    Giovanni Di Salvo, Angelo Fabio D’Aiello, Biagio Castaldi, Bahaa M. Fadel, Giuseppe Limongelli, Antonello D’Andrea, Valeria Pergola, Giuseppe Pacileo, Emanuele Miraglia del Giudice, Laura Perrone et al. · 2012 · Journal of the American Society of Echocardiography
  91. Type of LDLR Mutation and the Pharmacogenetics of Familial Hypercholesterolemia Treatment
    Paulo Caleb Júnior Lima Santos, Alexandre C. Pereira · 2015 · Pharmacogenomics
  92. The cost-effectiveness of screening strategies for familial hypercholesterolaemia in Poland
    Aleksandra Pelczarska, Michał Jakubczyk, Joanna Jakubiak-Lasocka, Maciej Banach, Małgorzata Myśliwiec, Marcin Gruchała, Maciej Niewada · 2018 · Atherosclerosis
  93. Disorders of Lipid Metabolism
    Clay F. Semenkovich, Anne Carol Goldberg, Ira J. Goldberg · 2011 · Elsevier eBooks
  94. Genetic Testing in Hyperlipidemia
    Ozlem Bilen, Yashashwi Pokharel, Christie Mitchell Ballantyne · 2016 · Endocrinology and Metabolism Clinics of North America
  95. Prevalence of familial hypercholesterolemia in premature coronary artery disease patients admitted to a tertiary care hospital in North India
    Jitendra P. S. Sawhney, Shashi Ranjan Prasad, Manish Kr. Sharma, Kushal Madan, A. K. Mohanty, Rajiv Passey, Ashwani Mehta, B. Kandpal, Aman Makhija, Rajneesh Jain et al. · 2019 · Indian Heart Journal
  96. The Importance of Cardiovascular Risk Assessment and Pregnancy Heart Team in the Management of Cardiovascular Disease in Pregnancy
    Garima V. Sharma, Wendy Ying, Candice K. Silversides · 2020 · Cardiology Clinics
  97. Cost-effectiveness of cascade genetic testing for familial hypercholesterolemia in the United States: A simulation analysis
    Candace L. Jackson, Todd R. Huschka, Bijan J. Borah, Katherine E. Agre, Magdi Zordok, Medhat Farwati, James P. Moriarty, Iftikhar J. Kullo · 2021 · American Journal of Preventive Cardiology
  98. Heterozygous Familial Hypercholesterolemia
    Angela C. Onorato, Amy Curry Sturm · 2016 · Circulation
  99. Genetic basis of index patients with familial hypercholesterolemia in Chinese population: mutation spectrum and genotype-phenotype correlation
    Di Sun, Bingyang Zhou, Sha Li, Ningling Sun, Qi Hua, Shulin Wu, Yunshan Cao, Yuan‐Lin Guo, Na‐Qiong Wu, Cheng‐Gang Zhu et al. · 2018 · Lipids in Health and Disease
  100. Recommendations for the management of patients with homozygous familial hypercholesterolaemia: Overview of a new European Atherosclerosis Society consensus statement
    Éric Bruckert · 2014 · Atherosclerosis Supplements